VolitionRx Overview
- Founded
-
1998

- Status
-
Public
- Employees
-
83

- Stock Symbol
-
VNRX

- Investments
-
4
- Share Price
-
$2.03
- (As of Friday Closing)
VolitionRx General Information
Description
VolitionRX Ltd is a us-based multi-national life sciences company. It is engaged in developing easy to use blood-based tests to accurately diagnose a range of cancers. The development pipeline includes assays to be used for symptomatic patients or asymptomatic populations. The company has developed more than 30 blood-based assays to detect specific biomarkers. It also develops Nucleosomics tests for several major cancers including CRC, pancreatic, lung and aggressive prostate. In addition, the company engages in the process of developing HyperGenomics tissue and blood-based tests to determine disease subtype following initial diagnosis and to help decide the appropriate therapy.
Contact Information
- 1 Scotts Road
- No 24-05 Shaw Centre
- Singapore, 228208
- Singapore
VolitionRx Stock Performance
(As of Friday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$2.03 | $2.05 | $1.85 - $4.14 | $115M | 56.8M | 76.1K | -$0.52 |
VolitionRx Financials Summary
In Thousands, USD |
TTM 31-Mar-2022 | FY 2021 31-Dec-2021 | FY 2020 31-Dec-2020 | FY 2019 31-Dec-2019 |
---|---|---|---|---|
EV | 145,077 | 148,693 | 170,049 | 178,301 |
Revenue | 179 | 90 | 13 | 17 |
EBITDA | (27,271) | (25,692) | (19,278) | (15,182) |
Net Income | (28,333) | (26,815) | (20,352) | (16,099) |
Total Assets | 31,683 | 27,490 | 26,151 | 21,291 |
Total Debt | 4,742 | 4,017 | 4,442 | 3,938 |
VolitionRx Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
VolitionRx Comparisons
Industry
VolitionRx Competitors (37)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Celyad Oncology | Formerly VC-backed | Mont-Saint-Guibert, Belgium | 000 | 00000 | 000000000 | 00000 |
000000 0000000 000 | Formerly VC-backed | Cambridge, MA | 000 | 00000 | 000000&0 | 00000 |
0000 0000 00000000 | Angel-Backed | West Palm Beach, FL | 00.000 | 0000000000 | 00.000 | |
00000000 | Private Debt Financed | Hayward, CA | 00 | 000000000 - | ||
0000 00000000000 | Formerly VC-backed | Cambridge, MA | 00 | 00000 | 00000000 | 00000 |
VolitionRx Executive Team (12)
VolitionRx Board Members (8)
Name | Representing | Role | Since |
---|---|---|---|
0000 000000 00.0 | VolitionRx | Board Member | 000 0000 |
0000000 00000000 | VolitionRx | Chief Executive Officer & Board Member | 000 0000 |
000000 0000000 00.0 | VolitionRx | Board Member | 000 0000 |
000 00000 | VolitionRx | Board Member | 000 0000 |
000 000000 | VolitionRx | Board Member | 000 0000 |
VolitionRx Signals
VolitionRx Investments & Acquisitions (4)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
0000000 (0000 | 10-Jan-2020 | 0000000000 | 00000 | Drug Delivery | 0000000 0 |
000000 000000 | 24-Feb-2015 | 000000000 | Buildings and Property | 0000000 0 | |
000000000 000 | 06-Oct-2011 | 0000000000 | 000.00 | Other Commercial Products | 000 00000 |
Plures Technologies | 15-Mar-2011 | Merger/Acquisition | Application Specific Semiconductors |
VolitionRx Subsidiaries (1)
Company Name | Industry | Location | Founded |
---|---|---|---|
0000000 (0000000) | Drug Delivery | Grafelfing, Germany |